NEW PIPERIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME

    公开(公告)号:JP2013253019A

    公开(公告)日:2013-12-19

    申请号:JP2010217446

    申请日:2010-09-28

    Applicant: KOWA CO

    Abstract: PROBLEM TO BE SOLVED: To provide a new compound having an action to promote insulin secretion from pancreatic &bgr; cells, and useful as a prophylactic and/or therapeutic agent for disorders caused by hyperglycemia, e.g. diabetes mellitus.SOLUTION: There is disclosed a compound expressed by general formula (1) or salt thereof or solvates thereof. In formula, one of A and B represents a nitrogen atom and the other thereof represents a nitrogen atom or CR; X represents an oxygen atom, sulfur atom, -(CH)-N(R)- or -(CH)-CH(R)-; Z represents a nitrogen atom when Y is an oxygen atom or sulfur atom, or Z represents an oxygen atom or sulfur atom when Y is a nitrogen atom; Rto Reach represents a hydrogen atom or another substituent.

    Novel substituted pyrimidine derivative and medicine comprising the same
    6.
    发明专利
    Novel substituted pyrimidine derivative and medicine comprising the same 审中-公开
    新型取代的吡哩啶衍生物及其药物

    公开(公告)号:JP2011136942A

    公开(公告)日:2011-07-14

    申请号:JP2009297783

    申请日:2009-12-28

    Abstract: PROBLEM TO BE SOLVED: To provide a novel compound that exhibits an effect for promoting insulin secretion from a pancreas β cell and is useful as a preventive and/or therapeutic agent for diseases caused by hyperglycemia, for example, diabetes. SOLUTION: The novel compound is a substituted pyrimidine derivative represented by general formula (1) [wherein the ring A is an optionally substituted 5 to 10-membered heteroaryl group; Q is an oxygen atom or the like; R 1 is a methyl group or the like; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are each independently a hydrogen atom or the like; m is an integer of 0-2; and n is an integer of 1-3] or a salt thereof, or a solvate thereof. COPYRIGHT: (C)2011,JPO&INPIT

    Abstract translation: 待解决的问题:提供一种具有促进胰腺β细胞胰岛素分泌的作用的新型化合物,可用作高血糖引起的疾病例如糖尿病的预防和/或治疗剂。 解决方案:新化合物是由通式(1)表示的取代嘧啶衍生物[其中环A是任选取代的5至10元杂芳基; Q是氧原子等; R 1是甲基等; R 2 ,R 3 ,R 4 ,R 5 ,R R 7,R SP< SP>,< SP> 9< SP>和R< SP> 10< SP>各自独立地为氢原子等; m是0-2的整数; n为1-3的整数)或其盐或其溶剂合物。 版权所有(C)2011,JPO&INPIT

Patent Agency Ranking